Fatty liver index as an indicator of metabolic syndrome

被引:28
作者
Rogulj, Dinko [2 ]
Konjevoda, Pasko [3 ]
Milic, Mirta [4 ]
Mladinic, Marin [4 ]
Domijan, Ana-Marija [1 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
[2] Polyclin Sunce, Zagreb, Croatia
[3] Rudjer Boskovic Inst, NMR Ctr, Zagreb, Croatia
[4] Inst Med Res & Occupat Hlth, Mutagenesis Unit, Zagreb 41000, Croatia
关键词
Fatty liver index; Metabolic syndrome; Oxidative stress; REPTree and SimpleCART algorithms; ROC curve analysis; C-REACTIVE PROTEIN; COMET ASSAY; DNA-DAMAGE; GAMMA-GLUTAMYLTRANSFERASE; OXIDATIVE DAMAGE; NATIONAL-HEALTH; ASSOCIATION; MARKERS; OBESITY; REPAIR;
D O I
10.1016/j.clinbiochem.2011.10.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: The aim of this study was to find an early indicator of metabolic syndrome (MetS). Design and methods: We measured several anthropometric, biochemical, haematological, and oxidative damage parameters in 128 middle-aged Caucasian men divided into two groups: patients with MetS (n=69) and healthy controls (n=59), and used Weka REPTree and SimpleCART algorithms to identify the most reliable predictor of MetS. Results: Oxidative damage parameters did not differ between the groups, suggesting that oxidative damage is less prominent at the early stage of MetS. The algorithms singled out fatty liver index (FLI) as the best variable for discriminating between healthy and MetS subjects. This finding was confirmed by the receiver-operating characteristic (ROC) curve analysis, which set FLI 68.53 as the threshold value for MetS diagnosis. Conclusions: FLI is the most reliable tool for diagnosing MetS. The absence of oxidative damage does not rule out oxidative stress but may indicate that MetS is at an early stage. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 35 条
[1]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[2]   Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications [J].
Berry, CE ;
Hare, JM .
JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03) :589-606
[3]  
Blaton VH, 2008, BIOCHEM MEDICA, V18, P14
[4]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[5]   The comet assay for DNA damage and repair - Principles, applications, and limitations [J].
Collins, AR .
MOLECULAR BIOTECHNOLOGY, 2004, 26 (03) :249-261
[6]   Pro-inflammatory cytokines and adipose tissue [J].
Coppack, SW .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) :349-356
[7]   DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements [J].
Demirbag, R. ;
Yilmaz, R. ;
Gur, M. ;
Celik, H. ;
Guzel, S. ;
Selek, S. ;
Kocyigit, A. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2006, 60 (10) :1187-1193
[8]  
Demircan N, 2008, MED SCI MONITOR, V14, pCR97
[9]   Comparison of urinary and plasma malondialdehyde in preterm infants [J].
Drury, JA ;
Nycyk, JA ;
Cooke, RWI .
CLINICA CHIMICA ACTA, 1997, 263 (02) :177-185
[10]  
Duvnjak Lea, 2008, Diabetologia Croatica, V37, P83